Evolution and Outcomes of Premature Coronary Artery Disease

Cara Lea Smith1, Matthew Seigerman2, Srinath Adusumalli2,3

  • 1Department of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Insights

Premature coronary artery disease (PCAD) affects younger individuals often missed by current risk assessments. Effective screening and targeted interventions are crucial for this growing cardiovascular disease burden.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Premature coronary artery disease (PCAD) impacts younger demographics, frequently overlooked by standard risk stratification tools.
  • PCAD constitutes a significant portion of cardiovascular disease and affects a population with stagnant mortality rates, contrasting with overall declining trends.
  • Existing risk models inadequately represent PCAD, highlighting a critical gap in cardiovascular disease prevention strategies.

Purpose of the Study:

  • To review the progression and outcomes associated with premature coronary artery disease (PCAD).
  • To examine effective screening strategies for identifying individuals at high risk for PCAD.
  • To explore opportunities for targeted interventions in PCAD prevention.

Main Methods:

  • Literature review of studies on premature coronary artery disease.
  • Analysis of current risk stratification guidelines and their limitations.
  • Evaluation of screening tools, imaging modalities, and pharmacotherapies for PCAD.

Main Results:

  • PCAD affects patients not typically identified by current risk tools.
  • Mortality rates for PCAD have plateaued, despite overall declines in cardiovascular mortality.
  • There is significant potential for improved screening and targeted therapies for PCAD.

Conclusions:

  • Proactive screening and aggressive risk factor modification are essential for younger populations at risk of PCAD.
  • Current risk calculation models need enhancement to better identify individuals susceptible to PCAD.
  • Precision pharmacotherapies and adapted imaging modalities offer promising avenues for PCAD management.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
170
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
644
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
116
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
141
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
122
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
471